These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8526205)

  • 21. An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study.
    Look KY; Brunetto VL; Clarke-Pearson DL; Averette HE; Major FJ; Alvarez RD; Homesley HD; Zaino RJ
    Gynecol Oncol; 1996 Dec; 63(3):304-11. PubMed ID: 8946863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the prognoses of FIGO stage I to stage II adenosquamous carcinoma and adenocarcinoma of the uterine cervix treated with radical hysterectomy.
    Mabuchi S; Okazawa M; Kinose Y; Matsuo K; Fujiwara M; Suzuki O; Morii E; Kamiura S; Ogawa K; Kimura T
    Int J Gynecol Cancer; 2012 Oct; 22(8):1389-97. PubMed ID: 22976497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of clinical outcomes of adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients receiving surgical resection followed by radiotherapy: a multicenter retrospective study (KROG 13-10).
    Noh JM; Park W; Kim YS; Kim JY; Kim HJ; Kim J; Kim JH; Yoon MS; Choi JH; Yoon WS; Kim JY; Huh SJ
    Gynecol Oncol; 2014 Mar; 132(3):618-23. PubMed ID: 24486605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histologic and immunophenotypic classification of cervical carcinomas by expression of the p53 homologue p63: a study of 250 cases.
    Wang TY; Chen BF; Yang YC; Chen H; Wang Y; Cviko A; Quade BJ; Sun D; Yang A; McKeon FD; Crum CP
    Hum Pathol; 2001 May; 32(5):479-86. PubMed ID: 11381365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenosquamous carcinoma of the cervix: prognosis in early stage disease treated by radical hysterectomy.
    Harrison TA; Sevin BU; Koechli O; Nguyen HN; Averette HE; Penalver M; Donato DM; Nadji M
    Gynecol Oncol; 1993 Sep; 50(3):310-5. PubMed ID: 8406193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
    Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Yoshioka Y; Sasano T; Ohta Y; Kamiura S; Ogawa K; Kimura T
    Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patterns of spread in node-positive cervical cancer: the relationship between local control and distant metastases.
    Stock RG; Chen AS; Karasek K
    Cancer J Sci Am; 1996; 2(5):256-62. PubMed ID: 9166542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.
    Uchiyama M; Iwasaka T; Matsuo N; Hachisuga T; Mori M; Sugimori H
    Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix.
    Nakanishi T; Ishikawa H; Suzuki Y; Inoue T; Nakamura S; Kuzuya K
    Gynecol Oncol; 2000 Nov; 79(2):289-93. PubMed ID: 11063659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The significance of Erb-b2 immunostaining in cervical cancer.
    Nevin J; Laing D; Kaye P; McCulloch T; Barnard R; Silcocks P; Blackett T; Paterson M; Sharp F; Cruse P
    Gynecol Oncol; 1999 Jun; 73(3):354-8. PubMed ID: 10366459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poor prognosis of patients with stage Ib1 adenosquamous cell carcinoma of the uterine cervix with pelvic lymphnode metastasis.
    Yasuda S; Kojima A; Maeno Y; Oki N; Miyahara Y; Sudo T; Takekida S; Yamaguchi S; Nishimura R
    Kobe J Med Sci; 2006; 52(1-2):9-15. PubMed ID: 16547424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ErbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients.
    Braun S; Schlimok G; Heumos I; Schaller G; Riethdorf L; Riethmüller G; Pantel K
    Cancer Res; 2001 Mar; 61(5):1890-5. PubMed ID: 11280743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glassy cell carcinoma of the cervix: a systematic review and meta-analysis.
    Guitarte C; Alagkiozidis I; Mize B; Stevens E; Salame G; Lee YC
    Gynecol Oncol; 2014 May; 133(2):186-91. PubMed ID: 24503463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glassy cell carcinoma of the uterine cervix a rare histology. Report of three cases with a review of the literature.
    Deshpande AH; Kotwal MN; Bobhate SK
    Indian J Cancer; 2004; 41(2):92-5. PubMed ID: 15318016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association between vascular endothelial growth factor, microvessel density and clinicopathological features in invasive cervical cancer.
    Tjalma W; Weyler J; Weyn B; Van Marck E; Van Daele A; Van Dam P; Goovaerts G; Buytaert P
    Eur J Obstet Gynecol Reprod Biol; 2000 Oct; 92(2):251-7. PubMed ID: 10996690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pathology of low-grade adenosquamous carcinoma of the breast. An immunohistochemical study.
    Drudis T; Arroyo C; Van Hoeven K; Cordon-Cardo C; Rosen PP
    Pathol Annu; 1994; 29 ( Pt 2)():181-97. PubMed ID: 7936747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prognosis analysis of 83 cases of cervical adenosquamous carcinoma].
    Yan M; Zhang YN; He JH; Huang H
    Ai Zheng; 2008 Sep; 27(9):956-61. PubMed ID: 18799035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of syndecan-1 with tumor grade and histology in primary invasive cervical carcinoma.
    Rintala M; Inki P; Klemi P; Jalkanen M; Grénman S
    Gynecol Oncol; 1999 Dec; 75(3):372-8. PubMed ID: 10600292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival.
    Giatromanolaki A; Koukourakis MI; Sivridis E; Fountzilas G
    Anticancer Res; 2000; 20(2A):997-1004. PubMed ID: 10810387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical analysis of 21 cases of cervical adenosquamous carcinoma].
    Cai HN; Wu XF; Xiang QY; Xiong YY; Zeng J
    Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):124-7. PubMed ID: 18683752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.